SHA:688276 Revenue

In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 591.81M CNY, down -51.85%. Changchun BCHT Biotechnology Co. had revenue of 117.37M in the quarter ending December 31, 2025, a decrease of -42.20%.

Revenue

591.81M

Revenue Growth

-51.85%

P/S Ratio

13.28

Revenue / Employee

464.53K

Employees

1,266

Market Cap

7.86B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	591.81M	-637.27M	-51.85%
Dec 31, 2024	1.23B	-595.60M	-32.64%
Dec 31, 2023	1.82B	753.24M	70.30%
Dec 31, 2022	1.07B	-130.58M	-10.86%
Dec 31, 2021	1.20B	-239.33M	-16.60%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sichuan Huiyu Pharmaceutical	998.15M
Jiangsu Kanion Pharmaceutical	3.13B
Sunflower Pharmaceutical Group Co.,Ltd	2.09B
Cisen Pharmaceutical	3.56B
Hubei Hongyuan Pharmaceutical Technology	1.77B
Dezhan Healthcare Company	389.51M
Zhejiang Tianyu Pharmaceutical	2.99B
Shandong Wit Dyne Health	2.36B

Revenue Rankings